General Information of This Metabolic Reaction (MR) (ID: MR012235)
Formula Reactant X-396 M577c/M577 Product X-396 M593a/b
Reactant Info Product Info
Metabolic Type Unclear - Unclear
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012232 X-396 X-396 M577c/M577 Oxidation - Mono-oxidation X-396 [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012233 X-396 M577c/M577 X-396 M575 Unclear - Unclear X-396 [1]
MR012237 X-396 M577c/M577 X-396 M753 Unclear - Unclear X-396 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012236 X-396 M593a/b X-396 M591a/b/c Unclear - Unclear X-396 [1]
References
1 Mass balance, metabolic disposition, and pharmacokinetics of [(14)C]ensartinib, a novel potent anaplastic lymphoma kinase (ALK) inhibitor, in healthy subjects following oral administration

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.